COVID-19 Treatment—Current Status, Advances, and Gap

COVID-19, which emerged in December 2019, was declared a global pandemic by the World Health Organization (WHO) in March 2020. The disease was caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It has caused millions of deaths worldwide and caused social and economic disruption....

Full description

Bibliographic Details
Main Authors: Chian Ho, Lee, Ping Chin
Format: Article
Language:English
English
Published: MDPI 2022
Subjects:
Online Access:https://eprints.ums.edu.my/id/eprint/35232/1/Abstract.pdf
https://eprints.ums.edu.my/id/eprint/35232/2/Full%20text.pdf
_version_ 1825715178206920704
author Chian Ho
Lee, Ping Chin
author_facet Chian Ho
Lee, Ping Chin
author_sort Chian Ho
collection UMS
description COVID-19, which emerged in December 2019, was declared a global pandemic by the World Health Organization (WHO) in March 2020. The disease was caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It has caused millions of deaths worldwide and caused social and economic disruption. While clinical trials on therapeutic drugs are going on in an Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) public–private partnership collaboration, current therapeutic approaches and options to counter COVID-19 remain few. Therapeutic drugs include the FDA-approved antiviral drugs, Remdesivir, and an immune modulator, Baricitinib. Hence, therapeutic approaches and alternatives for COVID-19 treatment need to be broadened. This paper discusses efforts in approaches to find treatment for COVID-19, such as inhibiting viral entry and disrupting the virus life cycle, and highlights the gap that needs to be filled in these approaches.
first_indexed 2024-03-06T03:22:52Z
format Article
id ums.eprints-35232
institution Universiti Malaysia Sabah
language English
English
last_indexed 2024-03-06T03:22:52Z
publishDate 2022
publisher MDPI
record_format dspace
spelling ums.eprints-352322023-03-23T02:12:51Z https://eprints.ums.edu.my/id/eprint/35232/ COVID-19 Treatment—Current Status, Advances, and Gap Chian Ho Lee, Ping Chin RA643-645 Disease (Communicable and noninfectious) and public health RA648.5-767 Epidemics. Epidemiology. Quarantine. Disinfection COVID-19, which emerged in December 2019, was declared a global pandemic by the World Health Organization (WHO) in March 2020. The disease was caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It has caused millions of deaths worldwide and caused social and economic disruption. While clinical trials on therapeutic drugs are going on in an Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) public–private partnership collaboration, current therapeutic approaches and options to counter COVID-19 remain few. Therapeutic drugs include the FDA-approved antiviral drugs, Remdesivir, and an immune modulator, Baricitinib. Hence, therapeutic approaches and alternatives for COVID-19 treatment need to be broadened. This paper discusses efforts in approaches to find treatment for COVID-19, such as inhibiting viral entry and disrupting the virus life cycle, and highlights the gap that needs to be filled in these approaches. MDPI 2022 Article PeerReviewed text en https://eprints.ums.edu.my/id/eprint/35232/1/Abstract.pdf text en https://eprints.ums.edu.my/id/eprint/35232/2/Full%20text.pdf Chian Ho and Lee, Ping Chin (2022) COVID-19 Treatment—Current Status, Advances, and Gap. Pathogens, 11. pp. 1-15. ISSN 2076-0817 https://www.mdpi.com/2076-0817/11/10/1201 https://doi.org/10.3390/pathogens11101201 https://doi.org/10.3390/pathogens11101201
spellingShingle RA643-645 Disease (Communicable and noninfectious) and public health
RA648.5-767 Epidemics. Epidemiology. Quarantine. Disinfection
Chian Ho
Lee, Ping Chin
COVID-19 Treatment—Current Status, Advances, and Gap
title COVID-19 Treatment—Current Status, Advances, and Gap
title_full COVID-19 Treatment—Current Status, Advances, and Gap
title_fullStr COVID-19 Treatment—Current Status, Advances, and Gap
title_full_unstemmed COVID-19 Treatment—Current Status, Advances, and Gap
title_short COVID-19 Treatment—Current Status, Advances, and Gap
title_sort covid 19 treatment current status advances and gap
topic RA643-645 Disease (Communicable and noninfectious) and public health
RA648.5-767 Epidemics. Epidemiology. Quarantine. Disinfection
url https://eprints.ums.edu.my/id/eprint/35232/1/Abstract.pdf
https://eprints.ums.edu.my/id/eprint/35232/2/Full%20text.pdf
work_keys_str_mv AT chianho covid19treatmentcurrentstatusadvancesandgap
AT leepingchin covid19treatmentcurrentstatusadvancesandgap